<DOC>
	<DOCNO>NCT00600509</DOCNO>
	<brief_summary>Double-blind , randomize , placebo-controlled , multi center trial evaluate efficacy safety levetiracetam adjunctive treatment adult Japanese epileptic subject partial onset seizure .</brief_summary>
	<brief_title>Bridging Study L059 ( Levetiracetam ) Patients With Epilepsy Double Blind Method</brief_title>
	<detailed_description />
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Etiracetam</mesh_term>
	<mesh_term>Piracetam</mesh_term>
	<criteria>simple and/or complex partial seizure without secondary generalization , first partial seizure &gt; = 2 year selection visit ; seizures classifiable accord ILAE classification ; minimum 12 partial seizure per 12 week minimum two partial seizure per 4 week selection visit end baseline period ; expose two standard AEDs ; take three standard AEDs , initiation trial . medication influence CNS , except medication take antiepileptic treatment ; partial seizure uncountable due clustering , include status epileptic , 3 month prior selection visit ; history cerebrovascular disease include transient ischemic attack ( TIA ) progressive cerebral disorder progressive neurological disorder ; presence history clinically significant allergic condition complication history significant alcohol abuse drug abuse past .</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>Levetiracetam</keyword>
	<keyword>Keppra</keyword>
</DOC>